Fluorinated ROS-responsive polycation enables noninvasive siRNA Delivery for the treatment of corneal neovascularization
Source abstract
Abstract
Corneal neovascularization (CNV) is a vision-threatening condition characterized by abnormal blood vessel growth into the avascular cornea, impairing its transparency and visual function. CNV is driven by an imbalance between pro- and anti-angiogenic factors, notably the overexpression of vascular endothelial growth factor (VEGF), exacerbated by inflammation and oxidative stress. Current treatments, including anti-VEGF and anti-inflammatory agents, are limited by poor bioavailability and invasive administration. In this study, we developed a fluorinated polycation for non-invasive delivery of siVEGFA along with ROS scavenging functionality to combat CNV. This multifunctional polymer exhibits enhanced ocular surface penetration via fluorination effect, efficient siRNA binding and delivery, and ROS-scavenging capacity. It demonstrated high biocompatibility, suppressed VEGFA expression, and significantly inhibited CNV progression in a mouse alkali burn model. These results highlight the promise of fluorinated, stimuli-responsive polymers as a dual-functional platform for safe, effective, and non-invasive treatment of ocular neovascular disorders. STATEMENT OF SIGNIFICANCE: CNV is a major cause of vision loss, yet current treatments rely on invasive injections or anti-inflammatory drugs, which can hinder corneal healing and reduce patient compliance. This study presents a fluorinated, ROS-responsive polycation that enables non-invasive, topical siRNA delivery while simultaneously combatting oxidative stress. Unlike conventional carriers, fluorination improves ocular penetration and intracellular delivery. By combining VEGFA knockdown with intrinsic antioxidant activity, this platform effectively suppresses neovascularization without delaying epithelial repair. This study advances the field of ocular gene therapy by offering a safer, injection-free alternative. It also highlights the potential of multifunctional polymer systems for treating chronic ocular vascular diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Corneal Surgery and Treatments · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Corneal neovascularization: updates on pathophysiology, investigations & management10.22336/rjo.2019.4 ↗
2. Corneal neovascularization10.1016/j.exer.2020.108363 ↗
3. Matrix revolution: molecular mechanism for inflammatory corneal neovascularization and restoration of corneal avascularity by epithelial stem cell transplantation10.1016/S1542-0124(12)70308-7 ↗
4. The association between corneal neovascularization and visual acuity: a systematic review10.1111/j.1755-3768.2011.02312.x ↗
5. Corneal angiogenic privilege and its failure10.1016/j.exer.2021.108457 ↗
6. Up-to-date molecular medicine strategies for management of ocular surface neovascularization10.1016/j.addr.2023.115084 ↗
7. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization10.1111/cbdd.13529 ↗
8. Oxidative stress in diseases of the human cornea, Free Radic
9. The role of oxidative stress in corneal diseases and injuries
10. The pathomechanism, antioxidant biomarkers, and treatment of oxidative stress-related eye diseases10.3390/ijms23031255 ↗
11. Mitochondrial dysfunction and oxidative stress in corneal disease10.1016/j.mito.2017.05.009 ↗
12. The novel role of lymphatic vessels in the pathogenesis of ocular diseases10.1016/j.preteyeres.2022.101157 ↗
13. Involvement of NADPH oxidases in alkali burn-induced corneal injury10.3892/ijmm.2016.2594 ↗
14. Hydrogen and N-acetyl-l-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model10.1167/iovs.10-6167 ↗
15. Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis10.1097/ICO.0b013e3182542613 ↗
16. An update on novel ocular nanosystems with possible benefits in the treatment of corneal neovascularization10.2147/IJN.S375570 ↗
17. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects10.1186/s12951-023-01992-2 ↗
18. Functional peptide-loaded gelatin nanoparticles as eyedrops for cornea neovascularization treatment10.2147/IJN.S398769 ↗
19. An injectable thermosensitive hydrogel for dual delivery of diclofenac and Avastin® to effectively suppress inflammatory corneal neovascularization10.1016/j.ijpharm.2022.122081 ↗
20. Poly(l-histidine)-mediated on-demand therapeutic delivery of roughened ceria nanocages for treatment of chemical eye injury10.1002/advs.202302174 ↗
21. T.-Y. Ger, C.-J. Yang, S. Ghosh, J.-Y. Lai, Biofunctionalization of nanoceria with sperminated hyaluronan enhances drug delivery performance for corneal alkali burn therapy, 476 (2023) 146864.10.1016/j.cej.2023.146864 ↗
22. Fluorinated multifunctional polymer vesicles for enhanced ocular surface penetration and synergistic treatment of dry eye disease10.1016/j.jconrel.2025.01.040 ↗
23. Multifunctional polymer vesicles for synergistic antibiotic-antioxidant treatment of bacterial keratitis10.1021/acs.biomac.3c00754 ↗
24. Origins and mechanisms of miRNAs and siRNAs10.1016/j.cell.2009.01.035 ↗
25. siRNA vs. shRNA: similarities and differences10.1016/j.addr.2009.04.004 ↗
26. RNA interference: biology, mechanism, and applications,10.1128/MMBR.67.4.657-685.2003 ↗
27. A crosslinked nucleic acid nanogel for effective siRNA delivery and antitumor therapy10.1002/anie.201711242 ↗
28. Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy10.1016/j.ejpb.2020.09.011 ↗
29. Engineered polymeric nanoparticles to guide the cellular internalization and trafficking of small interfering ribonucleic acids10.1016/j.jconrel.2017.02.019 ↗
30. Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticles10.1016/j.jconrel.2020.07.004 ↗
31. Efficient ocular delivery of siRNA via pH-sensitive vehicles for corneal neovascularization inhibition
32. Reactive oxygen species-responsive lipid nanoparticles for effective RNAi and corneal neovascularization therapy10.1021/acsami.1c23412 ↗
33. Liposome-trimethyl chitosan nanoparticles codeliver insulin and siVEGF to treat corneal alkali burns by inhibiting ferroptosis10.1002/btm2.10499 ↗
34. Fluorination promotes the cytosolic delivery of genes, proteins, and peptides10.1021/acs.accounts.1c00766 ↗
35. Fluoropolymers in biomedical applications: state-of-the-art and future perspectives10.1039/D0CS00258E ↗
36. Fluoropolymers for intracellular and in vivo protein delivery10.1016/j.biomaterials.2018.08.023 ↗
37. Fluorinated polymer mediated transmucosal peptide delivery for intravesical instillation therapy of bladder cancer
38. Fluorinated α-helical polypeptides synchronize mucus permeation and cell penetration toward highly efficient pulmonary siRNA delivery against acute lung injury10.1021/acs.nanolett.9b04957 ↗
39. A fluorinated peptide with high serum- and lipid-tolerence for the delivery of siRNA drugs to treat obesity and metabolic dysfunction10.1016/j.biomaterials.2022.121541 ↗
40. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios10.1038/ncomms4053 ↗
41. Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery10.1016/j.actbio.2016.09.023 ↗
42. Statistical versus block fluoropolymers in gene delivery10.1039/C8TB01470A ↗
43. Fluorinated lipid nanoparticles for enhancing mRNA delivery efficiency10.1021/acsnano.3c04507 ↗
44. Evaluation of the hydrophobicity of perfluoroalkyl chains in amphiphilic compounds that are incorporated into cell membrane10.1016/j.jfluchem.2011.01.004 ↗
45. The fluorination effect of fluoroamphiphiles in cytosolic protein delivery10.1038/s41467-018-03779-8 ↗
46. Highly retina-permeating and long-acting resveratrol/metformin nanotherapeutics for enhanced treatment of macular degeneration10.1021/acsnano.2c05824 ↗
47. Unveiling the power of gabapentin-loaded nanoceria with multiple therapeutic capabilities for the treatment of dry eye disease10.1021/acsnano.3c07817 ↗
48. RAFT polymerization-induced self-assembly as a strategy for versatile synthesis of semifluorinated liquid-crystalline block copolymer nanoobjects10.1021/acsmacrolett.8b00070 ↗
49. Triggered degradable colloidal particles with ordered inverse bicontinuous cubic and hexagonal mesophases10.1021/acsnano.0c09166 ↗
50. The effects of oral and topical corticosteroid in rabbit corneas10.1186/s12886-016-0339-5 ↗
51. Regulation of corneal angiogenesis in limbal stem cell deficiency10.1016/j.preteyeres.2006.09.001 ↗
52. Corneal neovascularization10.1016/j.exer.2020.108363 ↗
53. Management of corneal neovascularization with diathermy and intrastromal bevacizumab injection10.1097/ICL.0000000000001189 ↗
54. Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review10.1007/s00417-019-04519-4 ↗
55. A biocompatible oxidation-triggered carrier polymer with potential in therapeutics10.1021/ja110468v ↗
56. Reshaping tumor immune microenvironment through ROS-responsive prodrug polyplexes via synergistic effect of CRISPRi system and epigenetic inhibitor for breast cancer therapy
57. Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety10.1016/j.jare.2024.07.038 ↗
58. Construction of ROS-responsive poly(β-amino ester)-poly(β-thioether ester) copolymer for enhancing gene delivery and gene Therapy10.1021/acs.biomac.5c00954 ↗
59. Post cross-linked ROS-responsive poly(β-amino ester)-plasmid polyplex NPs for gene therapy of EBV-associated nasopharyngeal carcinoma10.1039/D3TB02926C ↗
60. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives10.1002/anie.200902672 ↗
61. Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption10.1021/la500057j ↗
62. Multifunctional fluoropolymer-engineered magnetic nanoparticles to facilitate blood-Brain barrier penetration and effective gene silencing in medulloblastoma10.1002/advs.202401340 ↗
63. Fluorinated polymer self-assembled nanomaterials: advances and biomedical applications10.1039/D5TB01933H ↗